Search results for "platinum"

showing 10 items of 629 documents

Efficient removal of bisphenol A from wastewaters: Catalytic wet air oxidation with Pt catalysts supported on Ce and Ce–Ti mixed oxides

2019

Catalytic wet air oxidation (CWAO) of an aqueous solution of bisphenol A (BPA) was investigated at 160 ℃ and 2.0 MPa of air in a batch reactor. Activity of supported platinum catalysts (2.5 wt%), prepared by wet impregnation, was compared with pure cerium and cerium–titanium oxide catalysts. Supported platinum catalysts showed higher activities in the removal of BPA than pure CeO2, Ce0.8Ti0.2O2 and Ce0.2Ti0.8O2. The oxidation reaction was followed the pseudo-first order rate law and the highest BPA removal, 97% and 95%, was achieved with Pt/CeO2 and Pt/Ce0.8Ti0.2O2 catalysts respectively. The CWAO of BPA aqueous solution was not a surface area specific reaction but the more important factor…

Bisphenol AAqueous solutionbisphenol ABatch reactorOxidechemistry.chemical_elementCatalysisCeriumchemistry.chemical_compoundchemistryXPSlcsh:TA401-492lcsh:Materials of engineering and construction. Mechanics of materialsCWAOplatinumWet oxidationPlatinumcerium–titaniumNuclear chemistryAIMS Materials Science
researchProduct

Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H…

2020

Abstract Objectives Given a lack of universally-accepted standard-of-care treatment for patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC), study objectives were to assess treatment utilization and survival outcomes for R/M HNSCC in the real-world setting. Materials and methods A multi-site retrospective chart review was conducted in Europe (Germany, United Kingdom, Italy, Spain), Asia Pacific (Australia, South Korea, Taiwan), and Latin/North America (Brazil and Canada) to identify patients who initiated first-line systemic therapy for R/M HNSCC between January 2011 and December 2013. Patients were followed through December 2015 to collect clinical characte…

Bridged-Ring CompoundsMaleCanadaCancer Researchmedicine.medical_specialtymedicine.medical_treatmentTaiwanMedizinCetuximabPlatinum CompoundsKaplan-Meier EstimateSystemic therapy03 medical and health sciences0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsRepublic of KoreaConfidence IntervalsmedicineHumans030223 otorhinolaryngologySurvival analysisAgedRetrospective StudiesChemotherapyCetuximabSquamous Cell Carcinoma of Head and Neckbusiness.industryHead and neck cancerAustraliaMiddle Agedmedicine.diseaseHead and neck squamous-cell carcinomaConfidence intervalEuropeRegimenMethotrexateTreatment OutcomeOncologyHead and Neck Neoplasms030220 oncology & carcinogenesisFemaleTaxoidsFluorouracilNeoplasm Recurrence LocalOral SurgerybusinessBrazilmedicine.drugOral Oncology
researchProduct

Immune escape of AKT overexpressing ovarian cancer cells

2012

Platinum-resistance is the most crucial problem for treatment of ovarian cancer. There is a clinical need for new treatment strategies which overcome platinum resistance. As survival is strongly influenced by immunological parameters, immunotherapeutic strategies appear promising. Therefore a better understanding of the interaction between ovarian tumour cells and cells of the immune system is a necessary prerequisite. In the present study we aimed to enlighten the interactions between platinum resistant and platinum sensitive ovarian cancer cells and natural-killer (NK)-cells. Modified FATAL assay was used for determining the killing efficiency of NK-cells for the parental A2780 cells and …

Cancer Researchendocrine system diseasesUbiquitin-Protein LigasesCellApoptosisBiologymedicine.disease_causeInhibitor of Apoptosis ProteinsImmune systemCell Line TumormedicineHumansPlatinumOvarian NeoplasmsCancerCell cyclemedicine.diseaseBaculoviral IAP Repeat-Containing 3 Proteinfemale genital diseases and pregnancy complicationsGene Expression Regulation NeoplasticKiller Cells Naturalmedicine.anatomical_structureOncologyDrug Resistance NeoplasmCell cultureApoptosisCancer researchFemaleOvarian cancerCarcinogenesisProto-Oncogene Proteins c-aktInternational Journal of Oncology
researchProduct

Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Inten…

2015

Objective Intensified preoperative treatments have been increasingly investigated in locally advanced rectal cancer (LARC), but limited data are available for the impact of these regimens on quality of life (QoL) and bowel function (BF). We assessed these outcome measures in EXPERT-C, a randomized phase 2 trial of neoadjuvant capecitabine combined with oxaliplatin (CAPOX), followed by chemoradiation therapy (CRT), total mesorectal excision, and adjuvant CAPOX with or without cetuximab in magnetic resonance imaging-defined, high-risk LARC. Methods and Materials QoL was assessed using the European Organization for Research and Treatment of Cancer QLQ-C30 and QLQ-CR29 questionnaires. Bowel inc…

Cancer Researchmedicine.medical_specialtyOrganoplatinum CompoundsColorectal cancerHealth StatusCetuximabAntineoplastic AgentsUrinary incontinenceBowel incontinenceSeverity of Illness Indexlaw.inventionRandomized controlled trialQuality of lifelawSurveys and QuestionnairesInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansFecal incontinenceRadiology Nuclear Medicine and imagingSexual Dysfunctions PsychologicalCapecitabineRadiationRectal Neoplasmsbusiness.industryRectumChemoradiotherapy Adjuvantmedicine.diseaseMagnetic Resonance ImagingTotal mesorectal excisionNeoadjuvant TherapyhumanitiesSurgeryOxaliplatinOncologyChemotherapy AdjuvantQuality of Lifemedicine.symptombusinessFecal IncontinenceChemoradiotherapyInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

Induction of micronucleated and binucleate cells in Chinese hamster ovary (CHO) cells by cis-diamminedichloroplatinum (II): a morphological and morph…

1990

Abstract The mutagenicity and cytotoxicity of cis -diamminedichloroplatinum (II) (cisplatin) at doses of 5, 10 and 20 μg/ml in Chinese hamster ovary (CHO) cells have been examined. A morphological characterization of several cell types induced by cisplatin was carried out. The frequencies of both cells with micronuclei and binucleate cells as a time-dependent parameter have also been studied. Whilst the number of cells with micronuclei was found to decrease with time, the number of binucleate cells increased. The possible kinetic mechanism for the production of binucleate cells and cells with micronuclei is discussed. A morphometric analysis was also performed. The nuclear area in both trea…

Cell NucleusGeneticsCisplatinCis diamminedichloroplatinum iiCell typeMicronucleus TestsDose-Response Relationship DrugChinese hamster ovary cellNuclear areaBiologyToxicologyMolecular biologyCricetinaeMicronucleus testGeneticsmedicineAnimalsCisplatinCytotoxicityInterphaseCell DivisionCells CulturedAfter treatmentmedicine.drugMutation Research/Genetic Toxicology
researchProduct

Saponins-mediated potentiation of cisplatin accumulation and cytotoxicity in human colon cancer cells.

2002

The triterpene saponins jenisseensosides A, B, C, D were found to increase the accumulation and cytotoxicity of the anticancer agent cisplatin in human colon tumor cells. These compounds are glycosides of quillaic acid whose fucose residue was acylated by a trans- or cis-p methoxycinnamic acid. In contrarst, other saponins derivatives without this acyl moiety were not found to potentiate the accumulation and cytotoxicity of cisplatin. These results suggested the importance of the acyl moiety for activity.

Cell SurvivalSaponinPharmaceutical SciencePlant RootsFucoseAnalytical Chemistrychemistry.chemical_compoundStructure-Activity RelationshipTriterpeneDrug DiscoverymedicineMoietyHumansOleanolic AcidCytotoxicitySilenePlatinumPharmacologychemistry.chemical_classificationCisplatinDose-Response Relationship DrugPlant ExtractsOrganic ChemistryGlycosideBiological activityDrug SynergismSaponinsTriterpenesComplementary and alternative medicinechemistryBiochemistryMolecular Medicinelipids (amino acids peptides and proteins)CisplatinHT29 Cellsmedicine.drugPlanta medica
researchProduct

Endoplasmic reticulum stress is involved in response of human laryngeal carcinoma cells to carboplatin but is absent in carboplatin resistant cells

2013

The major obstacle of successful tumor treatment with carboplatin (CBP) is the development of drug resistance. In the present study, we found that following treatment with CBP the amount of platinum which enters the human laryngeal carcinoma (HEp2)-derived CBP- resistant (7T) cells is reduced relative to the parental HEp2. As a consequence, the formation of reactive oxidative species (ROS) is reduced, the induction of endoplasmic reticulum (ER) stress is diminished, the amount of inter- and intrastrand cross-links is lower, and the induction of apoptosis is depressed. In HEp2 cells, ROS scavenger tempol, inhibitor of ER stress salubrinal, as well as gene silencing of ER stress marker CCAAT/…

Celllcsh:MedicineApoptosisCarboplatinSalubrinalapoptosis; carboplatin; drug resistance; endoplasmic reticulum stress; reactive oxidative species; tumor cellschemistry.chemical_compound0302 clinical medicineBlotting Southwesternlcsh:Science0303 health sciencesMultidisciplinaryThioureaGeologyEndoplasmic Reticulum Stress3. Good healthmedicine.anatomical_structure030220 oncology & carcinogenesisSignal transductionSignal TransductionResearch ArticleProgrammed cell deathCell SurvivalBlotting WesternBiologyReal-Time Polymerase Chain ReactionCyclic N-Oxides03 medical and health sciencesCell Line TumormedicineHumansGene SilencingLaryngeal NeoplasmsBiology030304 developmental biologyDNA PrimersPlatinumEndoplasmic reticulumlcsh:RCarcinomaMolecular biologychemistryCell cultureApoptosisCinnamatesDrug Resistance NeoplasmUnfolded protein responseCancer researchlcsh:QSpin LabelsReactive Oxygen Species
researchProduct

Platinum-doped CeO2 thin film catalysts prepared by magnetron sputtering.

2010

The interaction of Pt with CeO(2) layers was investigated by using photoelectron spectroscopy. The 30 nm thick Pt doped CeO(2) layers were deposited simultaneously by rf-magnetron sputtering on a Si(001) substrate, multiwall carbon nanotubes (CNTs) supported by a carbon diffusion layer of a polymer membrane fuel cell and on CNTs grown on the silicon wafer by the CVD technique. The synchrotron radiation X-ray photoelectron spectra showed the formation of cerium oxide with completely ionized Pt(2+,4+) species, and with the Pt(2+)/Pt(4+) ratio strongly dependent on the substrate. The TEM and XRD study showed the Pt(2+)/Pt(4+) ratio is dependent on the film structure.

Cerium oxideMaterials scienceAnalytical chemistryMineralogychemistry.chemical_elementSurfaces and InterfacesChemical vapor depositionSubstrate (electronics)Sputter depositionCondensed Matter PhysicschemistryX-ray photoelectron spectroscopySputteringElectrochemistryGeneral Materials ScienceThin filmPlatinumSpectroscopyLangmuir : the ACS journal of surfaces and colloids
researchProduct

Pt–CeO thin film catalysts for PEMFC

2015

Abstract Platinum is the mostly used element in catalysts for fuel cell technology, but its high price limits large-scale applications. Platinum doped cerium oxide represents an alternative solution due to very low loading, typically few micrograms per 1 cm2, at the proton exchange membrane fuel cell (PEMFC) anode. High efficiency is achieved by using magnetron sputtering deposition of cerium oxide and Pt of 30 nm thick nanoporous films on large surface carbon nanoparticle substrates. Thin film techniques permits to grow the catalyst film characterized by highly dispersed platinum, mostly in ionic Pt2+ state. Such dispersed Pt species show high activity and stability. These new materials ma…

Cerium oxideMaterials scienceNanoporousCatalyst supportInorganic chemistryProton exchange membrane fuel cellchemistry.chemical_elementGeneral ChemistrySputter depositionCatalysisCatalysischemistryThin filmPlatinumCatalysis Today
researchProduct

High efficiency of Pt2+ - CeO2 novel thin film catalyst as anode for proton exchange membrane fuel cells

2016

Abstract The elevated price of Pt limits the large-scale implementation of commercial proton exchange membrane fuel cells, which effectively convert chemical energy into electricity. In order to increase the cost-efficiency in proton-exchange membrane fuel cells, we have designed a family of novel anode catalysts consisting of thin films of ceria with low Pt loadings sputtered on a nanostructured carbon support. Remarkably, only such small amounts of Pt are necessary for achieving power density values comparable to the reference commercial catalysts, which results in excellent specific activities of our samples. By combining photoelectron spectroscopy and catalytic performance analysis, we …

Cerium oxideMaterials scienceSURFACEInorganic chemistrychemistry.chemical_elementProton exchange membrane fuel cell02 engineering and technology010402 general chemistry7. Clean energy01 natural sciencesCatalysisCatalysisWAVE BASIS-SETX-ray photoelectron spectroscopyNANOPARTICLESSPECTRAHYDROGENATIONThin filmThin filmGeneral Environmental SciencePLATINUMProcess Chemistry and TechnologyTOTAL-ENERGY CALCULATIONSCERIUM OXIDE-FILMSNANOSTRUCTUREFuel cellCerium oxide021001 nanoscience & nanotechnology0104 chemical sciencesAnodeELECTRONIC-STRUCTUREMembranechemistry0210 nano-technologyPlatinum
researchProduct